Cognos Announces U.S. Patent Award for Cerebral Microdialysis

[ad_1] INGLEWOOD, Calif., Nov. 06, 2023 (GLOBE NEWSWIRE) — Cognos Therapeutics, Inc. (“Cognos” or the “Company”), a medical technology company focused on developing implantable smart pump technology, today announced its…

Chardan Engaged to Facilitate Nocturne Acquisition Corporation’s Business Combination with Cognos Therapeutics, Inc., Paving the Way for NASDAQ Listing

[ad_1] WILMINGTON, Del. and INGLEWOOD, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) — Nocturne Acquisition Corporation (NASDAQ:MBTC, MBTCU, MBTCR) (“Nocturne”) and Cognos Therapeutics, Inc. (“Cognos”) today announced the engagement of Chardan,…